N C Schaper
Overview
Explore the profile of N C Schaper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasmussen N, Sarodnik C, Bours S, Schaper N, Souverein P, Jensen M, et al.
Osteoporos Int
. 2021 Oct;
33(3):599-610.
PMID: 34617151
Introduction: People with T1D have a higher incidence of fractures compared to the general population. However, sparse knowledge exists on the incidence rates of individual fracture sites. Therefore, we examined...
2.
Vergoossen L, Jansen J, de Jong J, Stehouwer C, Schaper N, Savelberg H, et al.
Geroscience
. 2020 Oct;
43(1):239-252.
PMID: 33034792
We assessed whether objectively measured low- and high-intensity physical activity (LPA and HPA) and sedentary time (ST) were associated with white matter connectivity, both throughout the whole brain and in...
3.
Janssen L, Hiligsmann M, Elissen A, Joore M, Schaper N, Bosma J, et al.
Diabet Med
. 2020 Mar;
37(10):1759-1765.
PMID: 32112462
Aims: To estimate the societal costs and quality of life of people with type 2 diabetes and to compare these results with those of people with normal glucose tolerance or...
4.
Hanssen N, Scheijen J, Houben A, van de Waarenburg M, Berendschot T, Webers C, et al.
Diabetes Metab
. 2020 Feb;
47(1):101148.
PMID: 32058030
Aims: Reactive dicarbonyl compounds, such as methylglyoxal (MGO), rise during an oral glucose tolerance test (OGTT), particularly in (pre)diabetes. Fasting MGO levels are associated with chronic kidney disease (CKD) and...
5.
Pickwell K, Geerts M, van Moorsel D, Hilkman D, Kars M, Schaper N
Diabet Med
. 2019 Sep;
37(2):350-355.
PMID: 31557355
Aim: To study cell-mediated immunity in the feet of people with type 2 diabetes with polyneuropathy. Methods: In a cohort comprising people with type 2 diabetes with polyneuropathy (n =...
6.
Hertroijs D, Elissen A, Brouwers M, Hiligsmann M, Schaper N, Ruwaard D
Diabet Med
. 2019 Apr;
37(11):1807-1815.
PMID: 31001855
Aims: Limited knowledge exists on the preferences of people with Type 2 diabetes towards diabetes care. Consequently, these care preferences cannot yet be considered in the development of tailored diabetes...
7.
Vluggen S, Hoving C, Schaper N, de Vries H
Contemp Clin Trials
. 2018 Oct;
74:38-45.
PMID: 30290275
Background: Many patients with type 2 diabetes mellitus (T2DM) sub-optimally adhere to core treatment recommendations, such as healthy diets, sufficient physical activity and pharmacological support. This paper describes the development...
8.
de Waard E, de Jong J, Koster A, Savelberg H, van Geel T, Houben A, et al.
Osteoporos Int
. 2018 Sep;
29(12):2725-2738.
PMID: 30209523
Introduction: To examine the association between diabetes status and volumetric bone mineral density (vBMD), bone microarchitecture and strength of the distal radius and tibia as assessed with HR-pQCT. Additionally-in participants...
9.
Sarodnik C, Bours S, Schaper N, van den Bergh J, van Geel T
Maturitas
. 2018 Feb;
109:70-77.
PMID: 29452785
Fracture risk in patients with type 2 diabetes mellitus (T2DM) is increased, and the mechanism is multifactorial. Recent research on T2DM-induced bone fragility shows that bone mineral density (BMD) is...
10.
Nielen J, Emans P, Van den Bemt B, Dagnelie P, Schram M, Stehouwer C, et al.
Diabetes Metab
. 2018 Feb;
44(3):296-299.
PMID: 29422359
No abstract available.